[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

GB0911846D0 - Animal models and therapeutic molecules - Google Patents

Animal models and therapeutic molecules

Info

Publication number
GB0911846D0
GB0911846D0 GBGB0911846.4A GB0911846A GB0911846D0 GB 0911846 D0 GB0911846 D0 GB 0911846D0 GB 0911846 A GB0911846 A GB 0911846A GB 0911846 D0 GB0911846 D0 GB 0911846D0
Authority
GB
United Kingdom
Prior art keywords
animal models
therapeutic molecules
therapeutic
molecules
models
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0911846.4A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genome Research Ltd
Original Assignee
Genome Research Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genome Research Ltd filed Critical Genome Research Ltd
Priority to GBGB0911846.4A priority Critical patent/GB0911846D0/en
Publication of GB0911846D0 publication Critical patent/GB0911846D0/en
Priority to DK14170196.1T priority patent/DK2798950T4/en
Priority to EP17174426.1A priority patent/EP3241435B1/en
Priority to HUE19207053A priority patent/HUE061788T2/en
Priority to ES19207053T priority patent/ES2948572T3/en
Priority to EP20120195041 priority patent/EP2604111A3/en
Priority to DK12194977.0T priority patent/DK2604110T3/en
Priority to EP14176740.0A priority patent/EP2792236B2/en
Priority to PT107345464T priority patent/PT2421357E/en
Priority to EP21169072.2A priority patent/EP3871497B1/en
Priority to EP19207050.6A priority patent/EP3622813B2/en
Priority to DK12171791.2T priority patent/DK2517556T4/en
Priority to EP23161385.2A priority patent/EP4215043A1/en
Priority to DK14176740.0T priority patent/DK2792236T4/en
Priority to EP16151215.7A priority patent/EP3028565B1/en
Priority to SI201030177T priority patent/SI2421357T1/en
Priority to DK19207053.0T priority patent/DK3622815T3/en
Priority to DK12194970.5T priority patent/DK2564695T3/en
Priority to DK17174426.1T priority patent/DK3241435T3/en
Priority to EP22155461.1A priority patent/EP4014729B1/en
Priority to EP20120194970 priority patent/EP2564695B1/en
Priority to PL12194970T priority patent/PL2564695T3/en
Priority to PL12171791T priority patent/PL2517556T3/en
Priority to LTEP17174426.1T priority patent/LT3241435T/en
Priority to EP12171793.8A priority patent/EP2517557B2/en
Priority to SG2014010995A priority patent/SG2014010995A/en
Priority to PL10734546T priority patent/PL2421357T3/en
Priority to ES12171791.2T priority patent/ES2557737T3/en
Priority to EP20100734546 priority patent/EP2421357B1/en
Priority to SG2011096427A priority patent/SG177380A1/en
Priority to DK12171793.8T priority patent/DK2517557T4/en
Priority to DK16151215.7T priority patent/DK3028565T3/en
Priority to ES17174426T priority patent/ES2884309T3/en
Priority to CA2767436A priority patent/CA2767436A1/en
Priority to EP21169076.3A priority patent/EP3871498B1/en
Priority to DK10734546.4T priority patent/DK2421357T3/en
Priority to EP19207052.2A priority patent/EP3622814B1/en
Priority to DK19207050.6T priority patent/DK3622813T4/en
Priority to AU2010269978A priority patent/AU2010269978B2/en
Priority to PL17174426T priority patent/PL3241435T3/en
Priority to ES21169074T priority patent/ES2978496T3/en
Priority to EP12194977.0A priority patent/EP2604110B1/en
Priority to BR112012000536-7A priority patent/BR112012000536A2/en
Priority to CN201080040055.5A priority patent/CN102638971B/en
Priority to ES21169072T priority patent/ES2974417T3/en
Priority to ES12194970.5T priority patent/ES2537239T3/en
Priority to PCT/GB2010/051122 priority patent/WO2011004192A1/en
Priority to EP12171791.2A priority patent/EP2517556B2/en
Priority to SI201032086T priority patent/SI3241435T1/en
Priority to HUE17174426A priority patent/HUE055817T2/en
Priority to JP2012519063A priority patent/JP5944312B2/en
Priority to CN201510587176.6A priority patent/CN105340834B/en
Priority to PT171744261T priority patent/PT3241435T/en
Priority to NZ597481A priority patent/NZ597481A/en
Priority to ES19207052T priority patent/ES2965212T3/en
Priority to KR1020127003297A priority patent/KR101875233B1/en
Priority to ES10734546T priority patent/ES2403087T3/en
Priority to NO14176740A priority patent/NO2792236T3/no
Priority to EP21169074.8A priority patent/EP3888457B1/en
Priority to EP14170196.1A priority patent/EP2798950B2/en
Priority to PT121949705T priority patent/PT2564695E/en
Priority to DK16151214.0T priority patent/DK3028564T5/en
Priority to PT121717912T priority patent/PT2517556E/en
Priority to EP19207053.0A priority patent/EP3622815B1/en
Priority to EP16151214.0A priority patent/EP3028564B2/en
Priority to US13/310,431 priority patent/US20120204278A1/en
Priority to US13/416,684 priority patent/US9447177B2/en
Priority to HK12113213.0A priority patent/HK1172207A1/en
Priority to HK13107869.8A priority patent/HK1180535A1/en
Priority to HK12102592.4A priority patent/HK1162119A1/en
Priority to HK15102886.6A priority patent/HK1202373A1/en
Priority to HK15101569.2A priority patent/HK1201026A1/en
Priority to US13/740,727 priority patent/US9505827B2/en
Priority to HRP20130253AT priority patent/HRP20130253T1/en
Priority to CY20131100261T priority patent/CY1113851T1/en
Priority to SM201300046T priority patent/SMT201300046B/en
Priority to US14/040,405 priority patent/US20140201856A1/en
Priority to US14/040,427 priority patent/US20140201854A1/en
Priority to US14/056,707 priority patent/US20140150126A1/en
Priority to US14/056,700 priority patent/US11812731B2/en
Priority to US14/056,434 priority patent/US20140182003A1/en
Priority to US14/080,630 priority patent/US10165763B2/en
Priority to US14/137,902 priority patent/US9434782B2/en
Priority to US14/497,054 priority patent/US20150113669A1/en
Priority to US14/516,461 priority patent/US10064398B2/en
Priority to JP2015022430A priority patent/JP6088562B2/en
Priority to US14/750,870 priority patent/US20160044900A1/en
Priority to US14/818,162 priority patent/US11564380B2/en
Priority to US14/935,010 priority patent/US9504236B2/en
Priority to US15/016,211 priority patent/US20160150768A1/en
Priority to US15/214,963 priority patent/US20160345551A1/en
Priority to US15/232,122 priority patent/US11606941B2/en
Priority to US15/251,969 priority patent/US20170051045A1/en
Priority to AU2016244326A priority patent/AU2016244326B2/en
Priority to US15/360,502 priority patent/US20170071174A1/en
Priority to US15/369,595 priority patent/US20170081423A1/en
Priority to US15/383,353 priority patent/US20170094956A1/en
Priority to US15/383,188 priority patent/US20170101482A1/en
Priority to US15/383,101 priority patent/US20170099815A1/en
Priority to US15/383,342 priority patent/US20170099816A1/en
Priority to US15/385,372 priority patent/US20170105396A1/en
Priority to US15/385,348 priority patent/US20170099817A1/en
Priority to JP2017017360A priority patent/JP6612275B2/en
Priority to AU2018206729A priority patent/AU2018206729C1/en
Priority to JP2019197622A priority patent/JP6930695B2/en
Priority to US16/870,413 priority patent/US20200375158A1/en
Priority to US16/870,365 priority patent/US20200352144A1/en
Priority to JP2020102978A priority patent/JP6876854B2/en
Priority to JP2020102976A priority patent/JP6876853B2/en
Priority to JP2020102977A priority patent/JP7141427B2/en
Priority to US16/905,557 priority patent/US20200352145A1/en
Priority to US16/905,537 priority patent/US20200337280A1/en
Priority to AU2021200079A priority patent/AU2021200079B2/en
Priority to HRP20211253TT priority patent/HRP20211253T1/en
Priority to US17/943,533 priority patent/US20240057572A1/en
Priority to US18/059,809 priority patent/US20230270088A1/en
Priority to US18/162,043 priority patent/US20230225302A1/en
Priority to US18/166,813 priority patent/US20230263143A1/en
Priority to CY20231100315T priority patent/CY1126083T1/en
Ceased legal-status Critical Current

Links

GBGB0911846.4A 2009-07-08 2009-07-08 Animal models and therapeutic molecules Ceased GB0911846D0 (en)

Priority Applications (119)

Application Number Priority Date Filing Date Title
GBGB0911846.4A GB0911846D0 (en) 2009-07-08 2009-07-08 Animal models and therapeutic molecules
DK14170196.1T DK2798950T4 (en) 2009-07-08 2010-07-07 Animal models and therapeutic molecules
EP17174426.1A EP3241435B1 (en) 2009-07-08 2010-07-07 Animal models and therapeutic molecules
HUE19207053A HUE061788T2 (en) 2009-07-08 2010-07-07 Rodent models and therapeutic molecules
ES19207053T ES2948572T3 (en) 2009-07-08 2010-07-07 Rodent models and therapeutic molecules
EP20120195041 EP2604111A3 (en) 2009-07-08 2010-07-07 Animal models and therapeutic molecules
DK12194977.0T DK2604110T3 (en) 2009-07-08 2010-07-07 Animal models and therapeutic molecules
EP14176740.0A EP2792236B2 (en) 2009-07-08 2010-07-07 Animal models and therapeutic molecules
PT107345464T PT2421357E (en) 2009-07-08 2010-07-07 Animal models and therapeutic molecules
EP21169072.2A EP3871497B1 (en) 2009-07-08 2010-07-07 Rodent models and therapeutic molecules
EP19207050.6A EP3622813B2 (en) 2009-07-08 2010-07-07 Animal models and therapeutic molecules
DK12171791.2T DK2517556T4 (en) 2009-07-08 2010-07-07 Method for point-specific recombination, rodents and rodent cells capable of expressing chimeric antibodies or chains
EP23161385.2A EP4215043A1 (en) 2009-07-08 2010-07-07 Animal models and therapeutic molecules
DK14176740.0T DK2792236T4 (en) 2009-07-08 2010-07-07 Animal models and therapeutic molecules
EP16151215.7A EP3028565B1 (en) 2009-07-08 2010-07-07 Animal models and therapeutic molecules
SI201030177T SI2421357T1 (en) 2009-07-08 2010-07-07 Animal models and therapeutic molecules
DK19207053.0T DK3622815T3 (en) 2009-07-08 2010-07-07 RODENT MODELS AND THERAPEUTIC MOLECULES
DK12194970.5T DK2564695T3 (en) 2009-07-08 2010-07-07 Animal models and therapeutic molecules
DK17174426.1T DK3241435T3 (en) 2009-07-08 2010-07-07 ANIMAL MODELS AND THERAPEUTIC MOLECULES
EP22155461.1A EP4014729B1 (en) 2009-07-08 2010-07-07 Rodent models and therapeutic antibodies
EP20120194970 EP2564695B1 (en) 2009-07-08 2010-07-07 Animal models and therapeutic molecules
PL12194970T PL2564695T3 (en) 2009-07-08 2010-07-07 Animal models and therapeutic molecules
PL12171791T PL2517556T3 (en) 2009-07-08 2010-07-07 Site-Specific Recombination Method, Rodents & Rodent Cells capable of Expressing Chimaeric Antibodies or Chains
LTEP17174426.1T LT3241435T (en) 2009-07-08 2010-07-07 Animal models and therapeutic molecules
EP12171793.8A EP2517557B2 (en) 2009-07-08 2010-07-07 Animal models and therapeutic molecules
SG2014010995A SG2014010995A (en) 2009-07-08 2010-07-07 Animal models and therapeutic molecules
PL10734546T PL2421357T3 (en) 2009-07-08 2010-07-07 Animal models and therapeutic molecules
ES12171791.2T ES2557737T3 (en) 2009-07-08 2010-07-07 Site-specific recombination method, rodents and rodent cells capable of expressing antibodies or chimeric chains
EP20100734546 EP2421357B1 (en) 2009-07-08 2010-07-07 Animal models and therapeutic molecules
SG2011096427A SG177380A1 (en) 2009-07-08 2010-07-07 Animal models and therapeutic molecules
DK12171793.8T DK2517557T4 (en) 2009-07-08 2010-07-07 Animal models and therapeutic molecules
DK16151215.7T DK3028565T3 (en) 2009-07-08 2010-07-07 ANIMAL MODELS AND THERAPEUTIC MOLECULES
ES17174426T ES2884309T3 (en) 2009-07-08 2010-07-07 Animal models and therapeutic molecules
CA2767436A CA2767436A1 (en) 2009-07-08 2010-07-07 Animal models and therapeutic molecules
EP21169076.3A EP3871498B1 (en) 2009-07-08 2010-07-07 Rodent models and therapeutic antibodies
DK10734546.4T DK2421357T3 (en) 2009-07-08 2010-07-07 ANIMAL MODELS AND THERAPEUTIC MOLECULES
EP19207052.2A EP3622814B1 (en) 2009-07-08 2010-07-07 Animal models and therapeutic molecules
DK19207050.6T DK3622813T4 (en) 2009-07-08 2010-07-07 ANIMAL MODELS AND THERAPEUTIC MOLECULES
AU2010269978A AU2010269978B2 (en) 2009-07-08 2010-07-07 Animal models and therapeutic molecules
PL17174426T PL3241435T3 (en) 2009-07-08 2010-07-07 Animal models and therapeutic molecules
ES21169074T ES2978496T3 (en) 2009-07-08 2010-07-07 Animal models and therapeutic molecules
EP12194977.0A EP2604110B1 (en) 2009-07-08 2010-07-07 Animal models and therapeutic molecules
BR112012000536-7A BR112012000536A2 (en) 2009-07-08 2010-07-07 methods for producing antibody or light or heavy chain of antibody specific to a desired antigen, for producing antibody or antibody chain and its use, pharmaceutical composition and chimeric antibody derivative
CN201080040055.5A CN102638971B (en) 2009-07-08 2010-07-07 Animal model and treatment molecule
ES21169072T ES2974417T3 (en) 2009-07-08 2010-07-07 Rodent models and therapeutic molecules
ES12194970.5T ES2537239T3 (en) 2009-07-08 2010-07-07 Animal models and therapeutic molecules
PCT/GB2010/051122 WO2011004192A1 (en) 2009-07-08 2010-07-07 Animal models and therapeutic molecules
EP12171791.2A EP2517556B2 (en) 2009-07-08 2010-07-07 Site-Specific Recombination Method, Rodents & Rodent Cells capable of Expressing Chimaeric Antibodies or Chains
SI201032086T SI3241435T1 (en) 2009-07-08 2010-07-07 Animal models and therapeutic molecules
HUE17174426A HUE055817T2 (en) 2009-07-08 2010-07-07 Animal models and therapeutic molecules
JP2012519063A JP5944312B2 (en) 2009-07-08 2010-07-07 Animal models and therapeutic molecules
CN201510587176.6A CN105340834B (en) 2009-07-08 2010-07-07 Animal model and treatment molecule
PT171744261T PT3241435T (en) 2009-07-08 2010-07-07 Animal models and therapeutic molecules
NZ597481A NZ597481A (en) 2009-07-08 2010-07-07 Animal models and therapeutic molecules
ES19207052T ES2965212T3 (en) 2009-07-08 2010-07-07 Animal models and therapeutic molecules
KR1020127003297A KR101875233B1 (en) 2009-07-08 2010-07-07 Animal models and therapeutic molecules
ES10734546T ES2403087T3 (en) 2009-07-08 2010-07-07 Animal models and therapeutic molecules
NO14176740A NO2792236T3 (en) 2009-07-08 2010-07-07
EP21169074.8A EP3888457B1 (en) 2009-07-08 2010-07-07 Rodent models and therapeutic molecules
EP14170196.1A EP2798950B2 (en) 2009-07-08 2010-07-07 Animal models and therapeutic molecules
PT121949705T PT2564695E (en) 2009-07-08 2010-07-07 Animal models and therapeutic molecules
DK16151214.0T DK3028564T5 (en) 2009-07-08 2010-07-07 ANIMAL MODELS AND THERAPEUTIC MOLECULES
PT121717912T PT2517556E (en) 2009-07-08 2010-07-07 Site-specific recombination method, rodents & rodent cells capable of expressing chimaeric antibodies or chains
EP19207053.0A EP3622815B1 (en) 2009-07-08 2010-07-07 Rodent models and therapeutic molecules
EP16151214.0A EP3028564B2 (en) 2009-07-08 2010-07-07 Animal models and therapeutic molecules
US13/310,431 US20120204278A1 (en) 2009-07-08 2011-12-02 Animal models and therapeutic molecules
US13/416,684 US9447177B2 (en) 2009-07-08 2012-03-09 Transgenic mouse homozygous for chimeric IgH locus
HK12113213.0A HK1172207A1 (en) 2009-07-08 2012-03-14 Animal models and therapeutic molecules
HK13107869.8A HK1180535A1 (en) 2009-07-08 2012-03-14 Animal models and therapeutic molecules
HK12102592.4A HK1162119A1 (en) 2009-07-08 2012-03-14 Animal models and therapeutic molecules
HK15102886.6A HK1202373A1 (en) 2009-07-08 2012-03-14 Animal models and therapeutic molecules
HK15101569.2A HK1201026A1 (en) 2009-07-08 2012-03-14 Animal models and therapeutic molecules
US13/740,727 US9505827B2 (en) 2009-07-08 2013-01-14 Animal models and therapeutic molecules
HRP20130253AT HRP20130253T1 (en) 2009-07-08 2013-03-21 Animal models and therapeutic molecules
CY20131100261T CY1113851T1 (en) 2009-07-08 2013-03-29 ANIMAL MODELS AND THERAPEUTIC PARTIES
SM201300046T SMT201300046B (en) 2009-07-08 2013-04-23 Animal models and therapeutic molecules
US14/040,405 US20140201856A1 (en) 2009-07-08 2013-09-27 Animal models and therapeutic molecules
US14/040,427 US20140201854A1 (en) 2009-07-08 2013-09-27 Animal models and therapeutic molecules
US14/056,707 US20140150126A1 (en) 2009-07-08 2013-10-17 Animal models and therapeutic molecules
US14/056,700 US11812731B2 (en) 2009-07-08 2013-10-17 Animal models and therapeutic molecules
US14/056,434 US20140182003A1 (en) 2009-07-08 2013-10-17 Animal models and therapeutic molecules
US14/080,630 US10165763B2 (en) 2009-07-08 2013-11-14 Animal models and therapeutic molecules
US14/137,902 US9434782B2 (en) 2009-07-08 2013-12-20 Animal models and therapeutic molecules
US14/497,054 US20150113669A1 (en) 2009-07-08 2014-09-25 Animal Models and Therapeutic Molecules
US14/516,461 US10064398B2 (en) 2009-07-08 2014-10-16 Animal models and therapeutic molecules
JP2015022430A JP6088562B2 (en) 2009-07-08 2015-02-06 Animal models and therapeutic molecules
US14/750,870 US20160044900A1 (en) 2009-07-08 2015-06-25 Animal models and therapeutic molecules
US14/818,162 US11564380B2 (en) 2009-07-08 2015-08-04 Animal models and therapeutic molecules
US14/935,010 US9504236B2 (en) 2009-07-08 2015-11-06 Animal models and therapeutic molecules
US15/016,211 US20160150768A1 (en) 2009-07-08 2016-02-04 Animal Models and Therapeutic Molecules
US15/214,963 US20160345551A1 (en) 2009-07-08 2016-07-20 Animal models and therapeutic molecules
US15/232,122 US11606941B2 (en) 2009-07-08 2016-08-09 Animal models and therapeutic molecules
US15/251,969 US20170051045A1 (en) 2009-07-08 2016-08-30 Animal models and therapeutic molecules
AU2016244326A AU2016244326B2 (en) 2009-07-08 2016-10-14 Animal models and therapeutic molecules
US15/360,502 US20170071174A1 (en) 2009-07-08 2016-11-23 Animal models and therapeutic molecules
US15/369,595 US20170081423A1 (en) 2009-07-08 2016-12-05 ANIMAL MODELS AND THERAPEUTIC MOLECULES - Track 1
US15/383,353 US20170094956A1 (en) 2009-07-08 2016-12-19 Animal models and therapeutic molecules
US15/383,188 US20170101482A1 (en) 2009-07-08 2016-12-19 Animal Models and Therapeutic Molecules
US15/383,101 US20170099815A1 (en) 2009-07-08 2016-12-19 Animal Models and Therapeutic Molecules
US15/383,342 US20170099816A1 (en) 2009-07-08 2016-12-19 Animal models and therapeutic molecules
US15/385,372 US20170105396A1 (en) 2009-07-08 2016-12-20 Animal Models and Therapeutic Molecules
US15/385,348 US20170099817A1 (en) 2009-07-08 2016-12-20 Animal Models and Therapeutic Molecules
JP2017017360A JP6612275B2 (en) 2009-07-08 2017-02-02 Animal models and therapeutic molecules
AU2018206729A AU2018206729C1 (en) 2009-07-08 2018-07-17 Animal models and therapeutic molecules
JP2019197622A JP6930695B2 (en) 2009-07-08 2019-10-30 Animal models and therapeutic molecules
US16/870,413 US20200375158A1 (en) 2009-07-08 2020-05-08 Animal Models and Therapeutic Molecules
US16/870,365 US20200352144A1 (en) 2009-07-08 2020-05-08 Animal Models and Therapeutic Molecules
JP2020102978A JP6876854B2 (en) 2009-07-08 2020-06-15 Animal models and therapeutic molecules
JP2020102976A JP6876853B2 (en) 2009-07-08 2020-06-15 Animal models and therapeutic molecules
JP2020102977A JP7141427B2 (en) 2009-07-08 2020-06-15 Animal models and therapeutic molecules
US16/905,557 US20200352145A1 (en) 2009-07-08 2020-06-18 Animal Models and Therapeutic Molecules
US16/905,537 US20200337280A1 (en) 2009-07-08 2020-06-18 Animal Models and Therapeutic Molecules
AU2021200079A AU2021200079B2 (en) 2009-07-08 2021-01-07 Animal models and therapeutic molecules
HRP20211253TT HRP20211253T1 (en) 2009-07-08 2021-08-04 Animal models and therapeutic molecules
US17/943,533 US20240057572A1 (en) 2009-07-08 2022-09-13 Animal Models and Therapeutic Molecules
US18/059,809 US20230270088A1 (en) 2009-07-08 2022-11-29 Animal Models and Therapeutic Molecules
US18/162,043 US20230225302A1 (en) 2009-07-08 2023-01-31 Animal Models and Therapeutic Molecules
US18/166,813 US20230263143A1 (en) 2009-07-08 2023-02-09 Animal Models and Therapeutic Molecules
CY20231100315T CY1126083T1 (en) 2009-07-08 2023-07-05 RODEN MODELS AND THERAPEUTIC MOLECULES

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0911846.4A GB0911846D0 (en) 2009-07-08 2009-07-08 Animal models and therapeutic molecules

Publications (1)

Publication Number Publication Date
GB0911846D0 true GB0911846D0 (en) 2009-08-19

Family

ID=41022330

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0911846.4A Ceased GB0911846D0 (en) 2009-07-08 2009-07-08 Animal models and therapeutic molecules

Country Status (1)

Country Link
GB (1) GB0911846D0 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2517556B1 (en) 2009-07-08 2015-11-18 Kymab Limited Site-Specific Recombination Method, Rodents & Rodent Cells capable of Expressing Chimaeric Antibodies or Chains

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2517556B1 (en) 2009-07-08 2015-11-18 Kymab Limited Site-Specific Recombination Method, Rodents & Rodent Cells capable of Expressing Chimaeric Antibodies or Chains

Similar Documents

Publication Publication Date Title
HK1201026A1 (en) Animal models and therapeutic molecules
HK1200872A1 (en) Animal models and therapeutic molecules
EP2426657A4 (en) Organ model
GB0803018D0 (en) Therapeutic compounds and their use
EP2300011A4 (en) Therapeutic methods and compounds
GB0804685D0 (en) Therapeutic compounds and their use
ZA201201287B (en) Therapeutic aryl-amido-aryl compounds and their use
GB0918392D0 (en) Diagnostic and therapeutic methods
GB201103609D0 (en) Improvements in animal training and devices
EP2438167A4 (en) Therapeutic and diagnostic molecules
GB0911846D0 (en) Animal models and therapeutic molecules
GB0913102D0 (en) Animal models and therapeutic molesules
GB0802128D0 (en) Therapeutic compounds and their use
ES1071307Y (en) CARRETON FOR TRAINING IN HARASSMENT-DERRIBO AND REJONEO PRACTICES
GB0913045D0 (en) Animal model
GB0913300D0 (en) Therapeutic compounds and their use
GB0921105D0 (en) Inhaler for humans and animals
AU2009900539A0 (en) Bacteriophage therapy in livestock

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)